Newsroom
Study Identifies Substantial Variability in the Cost of Prostate Cancer Surgery
Patients who want to compare prices for prostate-cancer surgery may find it rough going: a study has found a 13-fold difference in prices quoted by 100 hospitals across the United States. Moreover, most provided little more than broad estimates, and only three gave a hard copy of the charges.
Rosetta Genomics and Moffitt to Develop microRNA-Based Diagnostic
The agreement will help develop Rosetta's thyroid neoplasia assay.
Clinical Pathways, ACOs, COAs: Introducing 'Value' in Cancer Care
The continued advances in cancer treatment are improving patient survival, but the healthcare industry is bursting at its seams.
Taiho's RECOURSE Trial Meets Primary Endpoint for mCRC in Phase 3
Taiho Pharmaceutical Co., parent company of Taiho Oncology, announced recently that its combination drug for refractory metastatic colorectal cancer met its primary endpoint in a phase 3 global RECOURSE trial.
Coast-to-Coast Health Care Woe: Cost
From coast to coast, people say that their health coverage and care are too expensive.
Some States See in the Health Law a Chance to Pursue Unique Solutions
The federal health-care law was intended to create a uniform standard of health coverage across the U.S. But the law also is creating opportunities for states to pursue their own solutions.
Cleveland Clinic CEO Cosgrove Says No to VA Post
Cleveland Clinic CEO Dr. Toby Cosgrove will not take over the scandal-ridden Veterans Affairs Department and will remain in his current job.
White House Considering Toby Cosgrove, MD, president and CEO, Cleveland Clinic, to be the Next Secretary of the Department of Veterans Affairs.
The White House is considering Toby Cosgrove, MD, president and CEO, Cleveland Clinic, to be the next secretary of the Department of Veterans Affairs.
Study Identifies Growing Pains of Navigation and Survivorship Programs at Cancer Institutes
A study conducted at the GW Cancer Institute identified issues faced by cancer care institutes in adopting patient-centered care programs.
Nanotubes to Destroy Pancreatic Tumors from Within
Pristine nanotubes produced through a new process can be modified to carry drugs to tumors through gaps in blood-vessel walls that larger particles cannot fit through. The nanotubes may then target and infiltrate the cancerous cells' nuclei, where the drugs can be released through sonication.
What’s A Surgeon’s Role In An ACO? Not Much So Far, Survey Says
Accountable Care Organizations have given little attention to surgery in the early years of the Medicare program, choosing to focus instead on managing chronic conditions and reducing hospital readmissions.
Weight Loss Surgery Can Reduce Cancer Risk
Weight loss surgery might have more value than simply helping morbidly obese people to shed unhealthy extra pounds. It reduces their risk of cancer to rates almost similar to those of people of normal weight.
Anti-MET Antibody Fails to Impress in Phase 3 NSCLC Trial
Onartuzumab (MetMab)did not improve PFS when combined with erlotinib (Tarceva) in the METLung trial.
Path Cleared for Senate Vote on New Health Secretary
The Senate cleared the way for lawmakers to decide on Thursday whether to confirm Sylvia Mathews Burwell as secretary of health and human services.
ASCO to Help Cancer Docs Evaluate Treatment Value
The American Society of Clinical Oncology's algorithm to help oncologists evaluate the clinical benefits, side effects and costs of a cancer drug or therapy will be fine-tuned over the summer and should be available for public comment by the fall, said Dr. Lowell Schnipper, chair of the society's Value in Cancer Care Task Force.
Carl June Receives 2014 Taubman Prize for his Pioneering Work in Adoptive Cell Transfer
A physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells is the recipient of the 2014 Taubman Prize for Excellence in Translational Medical Science, awarded by the A. Alfred Taubman Medical Research Institute at the University of Michigan Medical School.
Medicaid Enrollment Surges By More Than 1 Million In April
Medicaid enrollment surged by more than 1 million people in April, bringing the total growth in the state-federal health insurance program for the poor since September to about 6 million, the Obama administration said Wednesday.
Ipilimumab for Early-Stage Melanoma?
Despite promising results, experts believe it's too early to use ipilimumab for early-stage melanoma, high toxicity being one of the limiting factors.
Phase 3 Studies of Lilly's CYRAMZA (ramucirumab): Significant Improvement in NSCLC Survival
Lilly's CYRAMZA (ramucirumab) significantly improved overall survival in phase 3 non-small cell lung cancer study. Results from the REVEL trial were published in The Lancet and also presented at ASCO 2014.
In The Literature: Improved Coverage Translates into Imrpoved Outcomes in Young Cancer Patients
The Patient Protection and Affordable Care Act (ACA) will likely improve insurance coverage for most young adults, but subsets of young adults in the United States will face significant premium increases in the individual market. We examined the association between insurance status and cancer-specific outcomes among young adults.
Study: EHR Access Could Influence ED Care
Knowledge is power. The statement holds true in the emergency department, as a new study has found that physician access to information in EHRs may have a significant impact on patient care.
State HIX Competition Grows
Many residents in New England are going to have more choices in the public exchanges this fall, as some insurers' growth strategies are tested.
Latest CMS Data Drop Shows Regional Variation in Spending on Inpatient, Post-Acute Care
The CMS' release of per capita spending for Medicare beneficiaries shows that some states, particularly in the South, Midwest and Mid-Atlantic, are spending significantly more on inpatient and post-acute care than northern and western states.
AJMC Panel: Advances in Multiple Myeloma Therapy Extend Survival for Patients, Raising Cost Concerns
The American Journal of Managed Care convened a panel of experts to discuss advances and challenges in treating multiple myeloma, which has seen longer survival rates since the arrival of bortezomib and thalidomide.